Morgan Stanley upgrades Lincoln National stock rating on Group Protection growth

Morgan Stanley upgraded Lincoln National (LNC) to Overweight, raising its price target to $58 from $41, citing an underappreciated Group Protection segment. This segment is projected to achieve a 26% compound annual growth rate from 2023-2026, significantly exceeding LNC's overall target and contributing to higher-quality, lower-capital-intensity earnings through strategic repricing and market execution. The upgrade comes as LNC trades at an attractive 6.6 P/E and below book value, despite a recent Q2 earnings beat on EPS but a miss on revenue.

Analysis

Morgan Stanley has upgraded Lincoln National (LNC) to Overweight from Equalweight, substantially raising its price target to $58.00 from $41.00. The core of this bullish thesis rests on the underappreciated value of LNC's Group Protection segment, which has been the primary driver of earnings outperformance over the last four quarters. Morgan Stanley projects this segment will achieve a 26% compound annual growth rate from 2023 to 2026, significantly outpacing the company's overall target of 13-16% and signaling a shift toward higher-quality, lower-capital-intensity earnings. This upgrade occurs while LNC trades at an attractive valuation with a P/E ratio of 6.6 and below its book value, despite a 31% year-to-date return. The positive outlook is supported by recent Q2 results, where EPS of $2.36 significantly beat the $1.89 consensus, although revenue of $4.04 billion fell short of the $4.66 billion expectation. Other analysts are also recognizing improving fundamentals, with CFRA and Wells Fargo raising their price targets to $42 and $37, respectively. Corporate actions, including the appointment of a new head for its Retirement Plan Services and the declaration of a $0.45 quarterly dividend, further signal strategic focus and commitment to shareholder returns.

Key Decisions for Investors

• Investors may view the Morgan Stanley upgrade as a strong bullish signal, focusing on the potential for a significant re-rating as the market recognizes the high-growth, high-quality earnings contribution from the Group Protection segment, which is not reflected in the current sub-book value valuation.
• The notable Q2 revenue miss, despite the strong EPS beat, is a key risk to monitor; investors should scrutinize future top-line growth to validate that strategic repricing and product expansion are translating into sustainable revenue gains.
• While Morgan Stanley's $58 price target is compelling, the more conservative targets from CFRA ($42) and Wells Fargo ($37) suggest a wide range of potential outcomes, warranting a risk-adjusted approach to position sizing.
• The declared $0.45 quarterly dividend provides income support and demonstrates management's confidence, making the stock a potential consideration for investors seeking a blend of value, growth, and yield.